Cargando…

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?

The purpose of this study was to investigate MRI features of triple-negative breast cancer (TNBC) compared with non-TNBC, to predict histopathological results. In the study, 26 patients with TNBC and 24 with non-TNBC who underwent multiparametric MRI of the breast on a 3 T magnet over a 10-months pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moffa, Giuliana, Galati, Francesca, Collalunga, Emmanuel, Rizzo, Veronica, Kripa, Endi, D’Amati, Giulia, Pediconi, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765199/ https://www.ncbi.nlm.nih.gov/pubmed/33333733 http://dx.doi.org/10.3390/diagnostics10121090

Ejemplares similares

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
por: Galati, Francesca, et al.
Publicado: (2022)

Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI
por: Rizzo, Veronica, et al.
Publicado: (2021)

Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity
por: Kripa, Endi, et al.
Publicado: (2022)

MRI as a biomarker for breast cancer diagnosis and prognosis
por: Galati, Francesca, et al.
Publicado: (2022)

Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score(®) Test?
por: Galati, Francesca, et al.
Publicado: (2022)

Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense Breasts
por: Moffa, Giuliana, et al.
Publicado: (2023)

Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge
por: Galati, Francesca, et al.
Publicado: (2023)

Special Issue “Advances in Breast MRI”
por: Galati, Francesca, et al.
Publicado: (2021)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
por: Mezi, Silvia, et al.
Publicado: (2021)

The phenotypic expression of mitochondrial tRNA-mutations can be modulated by either mitochondrial leucyl-tRNA synthetase or the C-terminal domain thereof
por: Giordano, Carla, et al.
Publicado: (2015)

Visceral adipose tissue area predicts intensive care unit admission in COVID-19 patients
por: Pediconi, Federica, et al.
Publicado: (2021)

NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
por: Diluvio, Giulia, et al.
Publicado: (2018)

Exploring the Ability of LARS2 Carboxy-Terminal Domain in Rescuing the MELAS Phenotype
por: Capriglia, Francesco, et al.
Publicado: (2021)

Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer
por: Cerbelli, Bruna, et al.
Publicado: (2020)

Initial clinical experience of non-invasive treatment of Magnetic Resonance guided high intensity focused Ultrasound (MRgFUS) for focal breast cancer
por: Marincola, Beatrice Cavallo, et al.
Publicado: (2014)

Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
por: Porta, Francesca Maria, et al.
Publicado: (2023)

Hematopoiesis and Mast Cell Development
por: Ribatti, Domenico, et al.
Publicado: (2023)

Bone angiocrine factors
por: Ribatti, Domenico, et al.
Publicado: (2023)

PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
por: Cerbelli, Bruna, et al.
Publicado: (2017)

Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC)
por: Fusco, Nicola, et al.
Publicado: (2022)

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis?
por: Gioia, Stefania, et al.
Publicado: (2019)

Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2021)

MRI and Adenomyosis: What Can Radiologists Evaluate?
por: Celli, Veronica, et al.
Publicado: (2022)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Unexpected endometrial malacoplakia related to abortion and placental rests retention: a case report
por: d’Amati, Antonio, et al.
Publicado: (2020)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Idiopathic noncirrhotic portal hypertension: current perspectives
por: Riggio, Oliviero, et al.
Publicado: (2016)

Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey
por: Fortunato, Lucio, et al.
Publicado: (2021)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
por: El Hejjioui, Brahim, et al.
Publicado: (2023)

Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis
por: Nandagopal, Srividhya, et al.
Publicado: (2023)

Extremely late-onset pulmonary metastasis from uterine PEComa
por: Ascione, Andrea, et al.
Publicado: (2022)

Idiopathic Non Cirrhotic Portal Hypertension and Spleno-Portal Axis Abnormalities in Patients with Severe Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2014)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

RUNX2: a prognostic biomarker for triple-negative breast cancer?
Publicado: (2014)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher, Brett, et al.
Publicado: (2016)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Triple-negative breast cancer: promising prognostic biomarkers currently in development
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vlskjhmha4cfoe102qv3i7itu5